Compare BSVN & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSVN | SLP |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 393.6M | 322.4M |
| IPO Year | 2018 | 1997 |
| Metric | BSVN | SLP |
|---|---|---|
| Price | $40.60 | $18.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $53.33 | $27.25 |
| AVG Volume (30 Days) | 9.8K | ★ 336.7K |
| Earning Date | 01-15-2026 | 01-08-2026 |
| Dividend Yield | ★ 2.64% | N/A |
| EPS Growth | ★ 19.43 | N/A |
| EPS | ★ 4.54 | N/A |
| Revenue | ★ $95,710,000.00 | $79,179,000.00 |
| Revenue This Year | N/A | $2.02 |
| Revenue Next Year | $2.23 | $6.92 |
| P/E Ratio | $9.00 | ★ N/A |
| Revenue Growth | 11.45 | ★ 13.09 |
| 52 Week Low | $32.49 | $12.39 |
| 52 Week High | $50.26 | $37.67 |
| Indicator | BSVN | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 40.26 | 52.87 |
| Support Level | $43.89 | $17.74 |
| Resistance Level | $45.50 | $19.62 |
| Average True Range (ATR) | 1.00 | 0.69 |
| MACD | -0.28 | -0.11 |
| Stochastic Oscillator | 15.98 | 48.71 |
Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.